These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 10757035

  • 1. In vivo therapeutic effects of IFN-gamma on human myelogenous leukemia in a severe combined immunodeficiency mouse model.
    Arai C, Tsuzaki Y, Nagano Y.
    In Vivo; 1999; 13(6):445-51. PubMed ID: 10757035
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The topoisomerase I inhibitor DX-8951f is active in a severe combined immunodeficient mouse model of human acute myelogenous leukemia.
    Vey N, Giles FJ, Kantarjian H, Smith TL, Beran M, Jeha S.
    Clin Cancer Res; 2000 Feb; 6(2):731-6. PubMed ID: 10690560
    [Abstract] [Full Text] [Related]

  • 5. Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.
    Studeny M, Marini FC, Dembinski JL, Zompetta C, Cabreira-Hansen M, Bekele BN, Champlin RE, Andreeff M.
    J Natl Cancer Inst; 2004 Nov 03; 96(21):1593-603. PubMed ID: 15523088
    [Abstract] [Full Text] [Related]

  • 6. Growth of sensitive and drug-resistant human myeloid leukemia cells in SCID mice.
    Beran M, Pisa P, Kantarjian H, Porwit A, Bjorkholm M.
    Hematol Pathol; 1994 Nov 03; 8(4):135-54. PubMed ID: 7860433
    [Abstract] [Full Text] [Related]

  • 7. JTE-607, a multiple cytokine production inhibitor, ameliorates disease in a SCID mouse xenograft acute myeloid leukemia model.
    Uesato N, Fukui K, Maruhashi J, Tojo A, Tajima N.
    Exp Hematol; 2006 Oct 03; 34(10):1385-92. PubMed ID: 16982331
    [Abstract] [Full Text] [Related]

  • 8. A diphtheria toxin-interleukin 3 fusion protein is cytotoxic to primitive acute myeloid leukemia progenitors but spares normal progenitors.
    Feuring-Buske M, Frankel AE, Alexander RL, Gerhard B, Hogge DE.
    Cancer Res; 2002 Mar 15; 62(6):1730-6. PubMed ID: 11912147
    [Abstract] [Full Text] [Related]

  • 9. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ, Jupudy V, Ostberg J, Oflazoglu E, Huberman A, Repasky E, Czuczman MS.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [Abstract] [Full Text] [Related]

  • 10. [Experimental study of 131I-labeled granulocyte macrophage colony-stimulating factor in SCID mouse-acute myeloid leukemia model].
    Deng YJ, Lou SF, Xu YZ.
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan 01; 28(1):33-6. PubMed ID: 17649724
    [Abstract] [Full Text] [Related]

  • 11. IFN-gamma induces apoptosis in ovarian cancer cells in vivo and in vitro.
    Wall L, Burke F, Barton C, Smyth J, Balkwill F.
    Clin Cancer Res; 2003 Jul 01; 9(7):2487-96. PubMed ID: 12855622
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Human myeloid and lymphoid malignancies in the non-obese diabetic/severe combined immunodeficiency mouse model: frequency of apoptotic cells in solid tumors and efficiency and speed of engraftment correlate with vascular endothelial growth factor production.
    Fusetti L, Pruneri G, Gobbi A, Rabascio C, Carboni N, Peccatori F, Martinelli G, Bertolini F.
    Cancer Res; 2000 May 01; 60(9):2527-34. PubMed ID: 10811135
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE, Herring B, Wilson LA, Rickford MS, Zhang M, Goldman CK, Tso JY, Waldmann TA.
    Cancer Res; 2000 Dec 15; 60(24):6977-84. PubMed ID: 11156399
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Antitumor effects of recombinant human prolactin in human adenocarcinoma-bearing SCID mice with human NK cell xenograft.
    Zhang J, Sun R, Wei H, Tian Z.
    Int Immunopharmacol; 2005 Feb 15; 5(2):417-25. PubMed ID: 15652770
    [Abstract] [Full Text] [Related]

  • 18. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY, Jolivet J, Leblond L, Hamelin B, Ouellet F, Barbeau S, Richard A, Gourdeau H.
    Cancer Chemother Pharmacol; 2003 Dec 15; 52(6):497-506. PubMed ID: 12955470
    [Abstract] [Full Text] [Related]

  • 19. In vivo antitumor activity of the NF-kappaB inhibitor dehydroxymethylepoxyquinomicin in a mouse model of adult T-cell leukemia.
    Ohsugi T, Horie R, Kumasaka T, Ishida A, Ishida T, Yamaguchi K, Watanabe T, Umezawa K, Urano T.
    Carcinogenesis; 2005 Aug 15; 26(8):1382-8. PubMed ID: 15831528
    [Abstract] [Full Text] [Related]

  • 20. [Relationship between anti-tumor effects of melphalan and IFN-gamma].
    Li ML, Li CG, Shu XH, Jia YJ, Qin ZH.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Sep 15; 22(5):594-6. PubMed ID: 16948903
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.